SCHEMBL7653726

SCHEMBL7653726

N#Cc1ccc2nc(CO)[nH]c2c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.59
PIN1 Q13526 1/20 0.57
GRIN1 Q05586 1/20 0.55
GRIN2B Q13224 1/20 0.55
NPSR1 Q6W5P4 1/20 0.54
PKN1 Q16512 1/20 0.52
PKN2 Q16513 1/20 0.52
CSNK1D P48730 6/20 0.50
GSK3B P49841 5/20 0.50
CSNK1A1 P48729 5/20 0.50
CSNK1G2 P78368 4/20 0.50
METAP2 P50579 1/20 0.49
METAP1 P53582 1/20 0.49
CHEK2 O96017 1/20 0.46
KMT2A Q03164 3/20 0.45
POLB P06746 2/20 0.45
THRB P10828 1/20 0.44
KDM4E B2RXH2 1/20 0.43
MEN1 O00255 1/20 0.43
NPC1 O15118 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7653718 0.87 TDP1 (0.47) TDP1PIN1GRIN1GRIN2BNPSR1
SCHEMBL7381841 0.84 GRIN1 (0.55) TDP1PIN1GRIN1GRIN2BPKN1
SCHEMBL3391734 0.84 GRIN1 (0.55) PIN1GRIN1GRIN2BPKN1PKN2
SCHEMBL4069591 0.82 PIN1 (0.63) PIN1GRIN1GRIN2BNPSR1PKN1
SCHEMBL22553665 0.81 GRIN1 (0.53) TDP1PIN1GRIN1GRIN2BPKN1
SCHEMBL7655135 0.81 RAD52 (0.61) TDP1PIN1GRIN1GRIN2BPKN1
SCHEMBL2712166 0.78 PIN1 (0.62) PIN1GRIN1GRIN2BPKN1PKN2
SCHEMBL15947556 0.78 KMT2A (0.72) TDP1PIN1NPSR1KMT2APOLB
SCHEMBL7653331 0.78 GRIN1 (0.53) PIN1GRIN1GRIN2BPKN1PKN2
SCHEMBL7659965 0.76 HTT (0.63) PIN1GRIN1GRIN2BCSNK1DGSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399642-B2 TRIS BENZIMIDAZOLES; FUNGICIDES, ANTICARCINOGENIC AGENTS, ENZYME INHIBITOR RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY 2002-06-04 US disclosed
US-20010009919-A1 Heterocyclic topoisomerase poisons RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY 2001-07-26 US disclosed
US-6221892-B1 Heterocyclic topoisomerase poisons THE STATE OF UNIVERSITY OF NEW JERSEY, RUTGERS 2001-04-24 US disclosed
EP-1054870-A1 HETEROCYCLIC TOPOISOMERASE POISONS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2000-11-29 EP disclosed
US-6063801-A Heterocyclic topoisomerase poisons RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2000-05-16 US disclosed
WO-1999041241-A1 HETEROCYCLIC TOPOISOMERASE POISONS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 1999-08-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010009919-A1 Heterocyclic topoisomerase poisons TOP1, TOP2A, TOP2B TDP1 4/4885PIN1 1184/4885GRIN1 2137/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.